WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2013

May 9, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2013-05-07

Reporting Person: JOHNSON L ROBERT (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-05-07	Common Stock	A	2003.0000	$0.0000	Acquired	28111.9300	Direct
2013-05-08	Common Stock	M	6400.0000	$36.1000	Acquired	34511.9300	Direct
2013-05-08	Common Stock	S	6400.0000	$64.4855	Disposed	28111.9300	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-05-08	Stock Option (Right to Buy)	$36.1000	M	6400.0000	Disposed	2016-05-02	Common Stock (6400.0000)	Direct

Footnotes

F1: These shares of restricted stock units will vest in 12 substantially equal monthly installments and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.